Navidea Biopharmaceuticals | Investor Presentation Deck

The slide uses a chemical structure diagram to illustrate the platform's modularity (dextran spine, mannose targeting, and replaceable payload).present_solution

Open slide detailBeat · Solution & Approach

present_solution

Open slide detailBeat · Solution & Approach

The slide uses a 'problem-solution' framing to justify the focus on RA.frame_problem

Open slide detailBeat · Problem & ComplicationLoop · Cost Of Inaction

The slide uses a color-coded list to distinguish between completed and ongoing studies.summarize

Open slide detailBeat · Problem & ComplicationLoop · Cost Of Inaction

The slide uses a visual comparison of patient hand scans (A vs B) alongside a color-coded response matrix to demonstrate predictive capability.show_traction

Open slide detailLoop · Quick Win Big Bet

The slide uses a vertical list format to describe two specific clinical use cases for the product.present_solution

Open slide detailLoop · Quick Win Big Bet

The slide outlines key regulatory steps including FDA meetings, Phase 3 status, and clinical trial enrollment targets.plan_implementation

Open slide detailLoop · Quick Win Big Bet

The chart displays a clear growth trajectory for the product, culminating in a 2036 peak sales figure of $1.2B.analyze_data

Open slide detailBeat · Visualization

The chart uses a stacked bar format to distinguish between U.S. and EU sales contributions over time.analyze_data

Open slide detailBeat · Visualization

transition

Open slide detail

Uses an analogy of a delivery system (GPS, drone, package) to explain a biological targeting mechanism.present_solution

Open slide detail

The slide uses a structured layout to show primary focus areas (Oncology, Anti-inflammatory) and secondary expansion areas (Fibrosis, Cardiovascular, Infectiouspresent_solution

Open slide detail

other

Open slide detail